Full history for every metric is available with a Kvantra account

Stock profile

Delta 9 Cannabis Inc. (DN.TO)

Country: CanadaSector: HealthcareIndustry: Drug Manufacturers - Specialty & GenericExchange: TSX

Delisted · last close 6 Aug 2024

Current price
0.01 CAD0.00%
Last close 6 Aug 2024
Benchmarks

Key financial summary

Financials in CAD
201820192020202120222023TTM
Total revenueCAD m8325262637171
Operating profitCAD m-22-18
Net profitCAD m-814-6-11-27-18-20
EPS reportedCAD-0.10-0.10
Operating cashflow per shareCAD0.020.02
Capex per shareCAD0.000.00
FCF per shareCAD0.010.01
Free cash flowCAD m34
Net debtCAD m6245
Book value equityCAD m-7-10
Book value per shareCAD-0.04-0.04
Number of sharesm178.94229.26
DPS (TTM paid)CAD0.000.00

Financial summary

Financials in CAD
201820192020202120222023TTM
Value
P/E TTMx--
P/B LTMx-0.61-0.15
P/S LTMx0.060.02
P/FCF LTMx1.740.42
EV/EBITDA LTMx-55.17-13.46
EV/Sales LTMx0.940.66
Earnings Yield LTM%-391.52%-1957.6%
FCF Yield%57.45%238.87%
Quality
ROE%240.59%4898.7%
ROIC%-36.66%-36.66%
Operating margin%-30.57%-30.57%
Gross margin%-3.38%-3.38%
FCF/Sales%3.62%3.62%
Growth and momentum
EPS Growth YoY%--
Sales Growth YoY%+12.39%+4.44%
Net Income Growth YoY%--
FCF Growth%--
Operating Profit Growth%--
Dividend and capital structure
Dividend Yield%0.00%0.00%
Dividend Growth%0.00%0.00%
Payout Ratio%0.00%0.00%
FCF/Debtx0.040.06
Net Debt/EBITDAx-51.48-51.48
EBIT/Net interestx-3.19-3.19
Net debt/market cap%1396.0%2991.5%
Net debt/Equityx-8.58-4.47
Gross debt/equityx-8.87-6.39

Company overview

Delta 9 Cannabis Inc. is a diversified enterprise operating across various segments of the cannabis industry. Its subsidiary, Delta 9 Bio-Tech Inc., handles the cultivation, processing, extraction, and distribution of both medicinal and recreational cannabis products, managing both wholesale and retail channels. The product portfolio spans dried cannabis flower, pre-rolled joints, dried sift, various oils, and a range of extracted and derivative offerings; notably, they also provide decontamination pods. Furthermore, Delta 9 supplies grow pods and live cannabis plants to other businesses, including those already licensed and those awaiting licensure. Beyond product sales, the company runs a medical clinic where physicians offer consultations to patients looking for a medical recommendation for cannabis prescriptions. As of April 20, 2022, Delta 9 operated a network of 35 branded retail outlets throughout the Canadian Prairies. Established in 2001, its corporate headquarters are located in Winnipeg, Canada.

WebsiteN/A
IndustryDrug Manufacturers - Specialty & Generic
CountryCanada
Trades inCAD

Similar companies

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Delisted · last close 6 Aug 2024

Delta 9 Cannabis Inc. (DN.TO)

DN.TO · TSX · Healthcare
0.01 CAD0.00%
Benchmarks
Financialsin CAD
20222023TTM
About

Delta 9 Cannabis Inc. is a diversified enterprise operating across various segments of the cannabis industry. Its subsidiary, Delta 9 Bio-Tech Inc., handles the cultivation, processing, extraction, and distribution of both medicinal and recreational cannabis products, managing both wholesale and retail channels. The product portfolio spans dried cannabis flower, pre-rolled joints, dried sift, various oils, and a range of extracted and derivative offerings; notably, they also provide decontamination pods. Furthermore, Delta 9 supplies grow pods and live cannabis plants to other businesses, including those already licensed and those awaiting licensure. Beyond product sales, the company runs a medical clinic where physicians offer consultations to patients looking for a medical recommendation for cannabis prescriptions. As of April 20, 2022, Delta 9 operated a network of 35 branded retail outlets throughout the Canadian Prairies. Established in 2001, its corporate headquarters are located in Winnipeg, Canada.

IndustryDrug Manufacturers - Specialty & Generic
CountryCanada
Trades inCAD

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Unlock all fundamental data

Sign up for Free

Unlock all fundamental data

Sign up for Free